The Impact of the COVID-19 Pandemic on Kidney Transplant Candidate Waitlist Status across Demographic and Geographic Groups: A National Analysis of UNOS STAR Data
- PMID: 36833146
- PMCID: PMC9956325
- DOI: 10.3390/healthcare11040612
The Impact of the COVID-19 Pandemic on Kidney Transplant Candidate Waitlist Status across Demographic and Geographic Groups: A National Analysis of UNOS STAR Data
Abstract
The primary goal of this retrospective study is to understand how the COVID-19 pandemic differentially impacted transplant status across race, sex, age, primary insurance, and geographic regions by examining which candidates: (i) remained on the waitlist, (ii) received transplants, or (iii) were removed from the waitlist due to severe sickness or death on a national level. Methods: The trend analysis aggregated by monthly transplant data from 1 December 2019 to 31 May 2021 (18 months) at the transplant center level. Ten variables about every transplant candidate were extracted from UNOS standard transplant analysis and research (STAR) data and analyzed. Characteristics of demographical groups were analyzed bivariately using t-test or Mann-Whitney U test for continuous variables and using Chi-sq/Fishers exact tests for categorical variables. Results: The trend analysis with the study period of 18 months included 31,336 transplants across 327 transplant centers. Patients experienced a longer waiting time when their registration centers in a county where high numbers of COVID-19 deaths were observed (SHR < 0.9999, p < 0.01). White candidates had a more significant transplant rate reduction than minority candidates (-32.19% vs. -20.15%) while minority candidates were found to have a higher waitlist removal rate than White candidates (9.23% vs. 9.45%). Compared to minority patients, White candidates' sub-distribution hazard ratio of the transplant waiting time was reduced by 55% during the pandemic period. Candidates in the Northwest United States had a more significant reduction in the transplant rate and a greater increase in the removal rate during the pandemic period. Conclusions: Based on this study, waitlist status and disposition varied significantly based on patient sociodemographic factors. During the pandemic period, minority patients, those with public insurance, older patients, and those in counties with high numbers of COVID-19 deaths experienced longer wait times. In contrast, older, White, male, Medicare, and high CPRA patients had a statistically significant higher risk of waitlist removal due to severe sickness or death. The results of this study should be considered carefully as we approach a reopening world post-COVID-19, and further studies should be conducted to elucidate the relationship between transplant candidate sociodemographic status and medical outcomes during this era.
Keywords: COVID-19; UNOS; kidney transplant; pandmeic; transplant.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
United Network for Organ Sharing (UNOS) Database Analysis of Factors Associated With Kidney Transplant Time on Waiting List.Cureus. 2023 Feb 6;15(2):e34679. doi: 10.7759/cureus.34679. eCollection 2023 Feb. Cureus. 2023. PMID: 36909033 Free PMC article.
-
COVID-19 and Access to Kidney Transplantation for Older Candidates in the United States: A National Registry Study.Kidney Med. 2023 Nov 27;6(1):100756. doi: 10.1016/j.xkme.2023.100756. eCollection 2024 Jan. Kidney Med. 2023. PMID: 38205431 Free PMC article.
-
Liver Transplantation in the Time of a Pandemic: A Widening of the Racial and Socioeconomic Health Care Gap During COVID-19.Ann Surg. 2021 Sep 1;274(3):427-433. doi: 10.1097/SLA.0000000000004994. Ann Surg. 2021. PMID: 34183513 Free PMC article.
-
Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist.JAMA Cardiol. 2020 Jun 1;5(6):660-668. doi: 10.1001/jamacardio.2020.0659. JAMA Cardiol. 2020. PMID: 32293647 Free PMC article.
-
Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates.Ann Transplant. 2019 Jun 28;24:383-392. doi: 10.12659/AOT.915769. Ann Transplant. 2019. PMID: 31249284 Free PMC article.
References
-
- Boyarsky B.J., Werbel W.A., Durand C.M., Avery R.K., Jackson K.R., Kernodle A.B., Snyder J., Hirose R., Massie I.M., Garonzik-Wang J.M., et al. Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am. J. Transplant. 2020;20:3131–3139. doi: 10.1111/ajt.16167. - DOI - PMC - PubMed
-
- Goffin E., Candellier A., Vart P., Noordzij M., Arnol M., Covic A., Lentini P., Malik S., Reichert L.J., Sever M.S., et al. COVID-19-related mortality in kidney transplant and haemodialysis patients: A comparative, prospective registry-based study. Nephrol. Dial. Transplant. 2021;36:2094–2105. doi: 10.1093/ndt/gfab200. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources